Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V2ZJ
|
|||
| Former ID |
DIB009012
|
|||
| Drug Name |
BCX-25
|
|||
| Synonyms |
BCX-14
Click to Show/Hide
|
|||
| Indication | Arthritis [ICD-11: FA20] | Terminated | [1] | |
| Company |
BioCryst Pharmaceuticals Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transferase unspecific (TF) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004493) | |||
| REF 2 | CN patent application no. 1096855, Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.